Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2011 Apr 1;332(6025):65-8.
doi: 10.1126/science.1200439. Epub 2011 Feb 24.

Chronic mucocutaneous candidiasis in humans with inborn errors of interleukin-17 immunity

Affiliations
Case Reports

Chronic mucocutaneous candidiasis in humans with inborn errors of interleukin-17 immunity

Anne Puel et al. Science. .

Abstract

Chronic mucocutaneous candidiasis disease (CMCD) is characterized by recurrent or persistent infections of the skin, nails, and oral and genital mucosae caused by Candida albicans and, to a lesser extent, Staphylococcus aureus, in patients with no other infectious or autoimmune manifestations. We report two genetic etiologies of CMCD: autosomal recessive deficiency in the cytokine receptor, interleukin-17 receptor A (IL-17RA), and autosomal dominant deficiency of the cytokine interleukin-17F (IL-17F). IL-17RA deficiency is complete, abolishing cellular responses to IL-17A and IL-17F homo- and heterodimers. By contrast, IL-17F deficiency is partial, with mutant IL-17F-containing homo- and heterodimers displaying impaired, but not abolished, activity. These experiments of nature indicate that human IL-17A and IL-17F are essential for mucocutaneous immunity against C. albicans, but otherwise largely redundant.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
A kindred with autosomal recessive IL-17RA deficiency. (A) Pedigree of the family established by IL-17RA genotyping. The proband is indicated by an arrow. E? indicates individuals whose genetic status could not be evaluated. (B) IL17RA DNA sequence electrophoregrams for a control and the patient. (C) Schematic diagram of the IL-17RA protein with the signal sequence (SS), extracellular (EC), transmembrane (TM), intracellular (IC) and SEFIR (similar expression to FGF/IL-17R) domains, and the position within the extracellular domain affected by the mutation.
Fig. 2
Fig. 2
Production and function of the mutant IL-17RA chain. (A) IL-17RA expression in SV40-immortalized fibroblasts from a control and the patient (top panel) and non adherent PBMCs (lower panel), as detected by flow cytometry. Isotype control (black); IL-17RA antibody (gray). (B) IL-6 and (C) GRO-α production by SV40-immortalized fibroblasts from a control, the patient, and NEMO-deficient cells after 24 hours of stimulation with IL-17A, IL-17F and IL-17A/IL-17F, mean +/- standard deviation (SD) error bars of three independent experiments, as detected by ELISA (UD. Undetectable). (D) IL-17RA expression in SV40-immortalized fibroblasts from the patient, transfected with the empty pORF9mcs plasmid (left panel) or the pORF9-hIL-17RA plasmid (right panel), as detected by flow cytometry. Isotype control (black); IL17RA antibody (gray). (E) IL-6 and (F) GRO-α production by SV40-immortalized fibroblasts from the patient, transfected with the empty pORF9mcs plasmid (white) or the pORF9-hIL17RA plasmid (gray), after 24 hours of stimulation with IL-17A, IL-17F and IL-17A/IL-17F, mean +/- SD error bars of three independent experiments, as detected by ELISA.
Fig. 3
Fig. 3
A kindred with autosomal dominant IL-17F deficiency. (A) Family pedigree, with allele segregation. The patients, shown in black, are all heterozygous for the mutation, as is II.8, who is asymptomatic. The proband is indicated by an arrow. E? indicates individuals whose genetic status could not be evaluated. III.3 is a nine-month-old baby, also heterozygous for the mutation and currently asymptomatic. All other family members are healthy and wild-type for IL17F and are shown in white. (B) Heterozygous c.284C>T mutation in the patients. IL17F DNA sequence electrophoregrams of a control and the patient III.2. (C) Ribbon trace of the IL-17F dimer. Beta strands are labeled. Sulfur atoms are shown in yellow. The position of the cavity that binds to the receptor is indicated by a black circle.
Fig. 4
Fig. 4
Function of the mutant IL-17F protein. (A) Production of IL-6 and (B) GROα by control SV-40 fibroblasts in response to increasing doses (ng/ml) of IL-17A, IL-17F wild-type (IL-17FWT), mutant IL-17F (IL-17FS65L), IL-17FWT/IL-17FS65L homodimers and of IL-17A/IL-17FWT and IL-17A/IL-17FS65L heterodimers for 24 hours, mean +/- SD error bars of three independent experiments, as detected by ELISA.

Comment in

Similar articles

Cited by

  • Human organoids with an autologous tissue-resident immune compartment.
    Recaldin T, Steinacher L, Gjeta B, Harter MF, Adam L, Kromer K, Mendes MP, Bellavista M, Nikolaev M, Lazzaroni G, Krese R, Kilik U, Popovic D, Stoll B, Gerard R, Bscheider M, Bickle M, Cabon L, Camp JG, Gjorevski N. Recaldin T, et al. Nature. 2024 Sep;633(8028):165-173. doi: 10.1038/s41586-024-07791-5. Epub 2024 Aug 14. Nature. 2024. PMID: 39143209 Free PMC article.
  • What are the 100 most cited fungal genera?
    Bhunjun CS, Chen YJ, Phukhamsakda C, Boekhout T, Groenewald JZ, McKenzie EHC, Francisco EC, Frisvad JC, Groenewald M, Hurdeal VG, Luangsa-Ard J, Perrone G, Visagie CM, Bai FY, Błaszkowski J, Braun U, de Souza FA, de Queiroz MB, Dutta AK, Gonkhom D, Goto BT, Guarnaccia V, Hagen F, Houbraken J, Lachance MA, Li JJ, Luo KY, Magurno F, Mongkolsamrit S, Robert V, Roy N, Tibpromma S, Wanasinghe DN, Wang DQ, Wei DP, Zhao CL, Aiphuk W, Ajayi-Oyetunde O, Arantes TD, Araujo JC, Begerow D, Bakhshi M, Barbosa RN, Behrens FH, Bensch K, Bezerra JDP, Bilański P, Bradley CA, Bubner B, Burgess TI, Buyck B, Čadež N, Cai L, Calaça FJS, Campbell LJ, Chaverri P, Chen YY, Chethana KWT, Coetzee B, Costa MM, Chen Q, Custódio FA, Dai YC, Damm U, Santiago ALCMA, De Miccolis Angelini RM, Dijksterhuis J, Dissanayake AJ, Doilom M, Dong W, Álvarez-Duarte E, Fischer M, Gajanayake AJ, Gené J, Gomdola D, Gomes AAM, Hausner G, He MQ, Hou L, Iturrieta-González I, Jami F, Jankowiak R, Jayawardena RS, Kandemir H, Kiss L, Kobmoo N, Kowalski T, Landi L, Lin CG, Liu JK, Liu XB, Loizides M, Luangharn T, Maharachchikumbura SSN, Mkhwanazi GJM, Manawasinghe IS, Marin-Felix Y, McTaggart AR, Moreau PA, Morozova OV, Mostert L, … See abstract for full author list ➔ Bhunjun CS, et al. Stud Mycol. 2024 Jul;108:1-411. doi: 10.3114/sim.2024.108.01. Epub 2024 Jul 15. Stud Mycol. 2024. PMID: 39100921 Free PMC article.
  • Integrated Analysis of Transcriptome Profiles and lncRNA-miRNA-mRNA Competing Endogenous RNA Regulatory Network to Identify Biological Functional Effects of Genes and Pathways Associated with Johne's Disease in Dairy Cattle.
    Ghafouri F, Dehghanian Reyhan V, Sadeghi M, Miraei-Ashtiani SR, Kastelic JP, Barkema HW, Shirali M. Ghafouri F, et al. Noncoding RNA. 2024 Jun 28;10(4):38. doi: 10.3390/ncrna10040038. Noncoding RNA. 2024. PMID: 39051372 Free PMC article.
  • Epithelial responses to fungal pathogens.
    Mills KAM, Aufiero MA, Hohl TM. Mills KAM, et al. Curr Opin Microbiol. 2024 Aug;80:102508. doi: 10.1016/j.mib.2024.102508. Epub 2024 Jul 10. Curr Opin Microbiol. 2024. PMID: 38986398 Review.
  • Candida albicans and Candida glabrata: global priority pathogens.
    Katsipoulaki M, Stappers MHT, Malavia-Jones D, Brunke S, Hube B, Gow NAR. Katsipoulaki M, et al. Microbiol Mol Biol Rev. 2024 Jun 27;88(2):e0002123. doi: 10.1128/mmbr.00021-23. Epub 2024 Jun 4. Microbiol Mol Biol Rev. 2024. PMID: 38832801 Review.

References

    1. Puel A, et al. Curr Opin Immunol. 2010 Aug;22:467. - PMC - PubMed
    1. de Beaucoudrey L, et al. J Exp Med. 2008 Jul 7;205:1543. - PMC - PubMed
    1. Ma CS, et al. J Exp Med. 2008 Jul 7;205:1551. - PMC - PubMed
    1. Minegishi Y, et al. J Exp Med. 2009 Jun 8;206:1291. - PMC - PubMed
    1. Milner JD, et al. Nature. 2008 Apr 10;452:773. - PubMed

Publication types

Associated data